Shareholder letter - Tuesday February 17, 2015
Link to document.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
January 28, 2016
RegeneRx U.S. Joint Venture, ReGenTree, Launches Web Site
December 4, 2015
RegeneRx Receives Chinese Patent for Key TB4 Peptide Fragment
October 28, 2015
RegeneRx Analyst Report Update Issued by SeeThruEquity, LLC